Phase I trial of R 548 in volunteers.
Latest Information Update: 09 Jan 2012
Price :
$35 *
At a glance
- Drugs R 548 (Primary)
- Indications Immunological disorders; Transplant rejection
- Focus Adverse reactions
- 09 Jan 2012 New trial record
Latest Information Update: 09 Jan 2012